Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 9(18), p. 678-690
DOI: 10.3111/13696998.2015.1040024
Links
Tools
Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy
Journal article published in 2015 by
Sandrine Cure,
Ines Guerra,
Calogero Cammà,
Antonio Craxì 
,
Giampiero Carosi
,
Giampiero Carosi
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 